Lung Cancer - Featured Clinical Trials
The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:
- Treating Lung Cancer in Nonsmokers and Former Light Smokers
(Posted: 01/09/2007) - In this trial, previously untreated non-small cell lung cancer patients who never smoked or are former light smokers will be treated with either erlotinib alone or erlotinib in combination with the drugs carboplatin and paclitaxel.
- Gene Therapy for Metastatic Cancer
(Posted: 11/21/2006) - In the trial, researchers will harvest normal T lymphocytes from patients' blood and modify these immune system cells to recognize p53 protein, a common hallmark of many cancers. The modified cells will be enriched in the laboratory and then infused back into the patients.
- Combining Targeted Therapies for Thoracic Cancers
(Posted: 09/26/2006) - In this trial, patients with advanced thoracic cancers (cancers of the chest) or other cancers that have spread to the chest will be treated with the drugs romidepsin and flavopiridol. Researchers will study the safety of this combination and how these agents affect gene and protein expression in these patients.
- Targeted Treatment for Recurrent or Progressive Lung Cancer
(Posted: 10/18/2005, Updated: 05/02/2006) - In this clinical trial, researchers are testing a new drug called sorafenib to see if it can cause tumors to shrink or disappear in patients with metastatic non-small cell lung cancer (NSCLC) that has recurred or progressed after previous treatment with chemotherapy.
- Chemoprevention Study of Selenium for Non-Small Cell Lung Cancer
(Posted: 04/06/2004, Updated: 08/09/2005) - Researchers are investigating selenium as a chemoprevention agent to combat the development of secondary lung cancer tumors.